Objective: The clinical application of centrifugal ventricular assist devices (VAD) has generally been limited to adults and large paediatric patients. In our experience neonates and small paediatric patients requiring ventricular support post-cardiopulmonary bypass are well supported by VAD. In this study we analyse our experience. Methods: We have examined the records of our VAD patients who weighed less than 6 kg. Thirty-four patients, ranging in age from 2 to 258 days (median 60 days) and weight from 1.9 to 5.98 kg (median 3.7 kg), underwent 35 VAD procedures. One patient was supported on VAD twice. Results: All patients had congenital heart lesions and were placed on VAD either because they could not be weaned from cardiopulmonary bypass after repair or palliation of the lesion (71.5%), or for support in the post-operative period due to refractory low cardiac output (28.5%). Twenty-two of the 35 VAD procedures (0.63, 95% CI: 0.45 -0.78) resulted in successful weaning and decannulation, this was similar to the weaning probability for patients greater than 6 kg (P= 0.07). There were 10 late deaths in this group, with a 1-year KM survival of 0.31 (95% CI: 0.17-0.47). Most late deaths were related to irreversible cardiac disease processes as were the elective discontinuance of VAD outcomes. Neither weight, age, VAD duration, CPB duration, X clamp duration, univentricular anatomy or TGA anatomy predicted successful discharge from hospital (P \ 0.05) -Weight P = 0.576; Age P=0.532; VAD duration P=0.181; CBP duration P=0.549; X clamp duration P = 0.984; Univentricular anatomy P =0.481; TGA anatomy P=0.099. Conclusion: We believe centrifugal ventricular assist is a realistic option in very small patients who require post-cardiopulmonary bypass support. It is relatively easy to establish and manage, the results, although showing no factors predictive of successful discharge, are encouraging.
Introduction
Ventricular assist devices (VAD) utilizing centrifugal pumps have in the past been used infrequently for neonatal and very small paediatric patients. Within the paediatric age group, most of the world's experience has been in patients between over 6 and 10 kg, with smaller patients generally supported with ECMO. VAD has been used in our hospital for children of any size who cannot be weaned from cardiopulmonary bypass (CPB), for post-operative low cardiac output that fails to respond to pharmacological intervention and unoperated patients with irreversible cardiac dysfunction (planned bridge to transplant). All children must meet a number of criteria before VAD is initiated. The ventricular dysfunction should be potentially reversible. The repair or palliative procedure should have been adequate. Contra-indications include irreversible dysfunction associated with other major organs, intracranial haemorrhage, neurologic impairment or sepsis [1] . In this study we analyse the results of this VAD strategy in patients under 6 kg, including indications, techniques, long and short term outcome, and incremental risk factors. heart defects. Among the 34 patients, the most common defect was hypoplastic left heart syndrome (12 patients) followed by transposition of the great arteries (eight patients) and complete atrioventricular septal defect (three patients; Table 1 ). Twenty-five procedures were performed for children who could not be weaned from CPB, and 10 for low cardiac output in the postoperative period following initially successful separation from CPB. The time from the end of CPB to the initiation of VAD in these latter 10 procedures ranged from 3 to 96 h (median 23.5 h). The duration of support for all procedures ranged from 1 to 131 h (median 68 h, mean 58.3 h). The patient who underwent two VAD procedures could not be weaned from CPB, was placed on VAD, weaned and decannulated, and then required another course of VAD due to low cardiac output.
Materials and methods
All patients were supported with a circuit consisting of a centrifugal pump head and flow probe (Medtronic, Biopump, Eden Prairie, MN), PVC tubing, aortic and venous cannulae from various manufacturers and pump inlet and outlet pressure monitoring lines as shown in Fig. 1 . All patients had blood withdrawn from the left or common atrium and delivered to the ascending aorta. When patients could not be weaned from CPB, despite maximum appropriate pharmacological intervention, right ventricular and pulmonary function were evaluated while still on CBP to assess the suitability for VAD. The left atrial cannula was inserted and conDuring the period 1989 -1996, 1180 open heart operations were performed on patients under 6 kg in this institution. Thirty-five VAD procedures were carried out on 34 patients. VAD was thus required in 3% of cases in this patient group. The 34 patients ranged in age from 2 to 258 days (median 37 days) and weight from 1.9 to 5.98 kg (median 3.47 kg). All patients had been operated on for repair or palliation of congenital nected (via a 'Y' connector) to the venous line of the CPB circuit. The right atrial cannula was clamped and blood from the left atrium drained by gravity into the venous reservoir of the oxygenator. In patients with univentricular anatomy no cannula changes were needed. The ventilation was increased to pre-bypass values, the oxygenator gas sweep was turned off and the oxygenator FiO 2 was reduced to 21%. While on VAD using the CPB circuit, right ventricular (RV) and pulmonary artery pressures and function were observed. At full flow good contraction of the RV and right atrial pressure less than 12 mmHg (without pulmonary hypertension or right heart distension) indicated that right heart function may be adequate to allow use of VAD. Serial blood gases were analysed to evaluate lung function. If oxygenation, CO 2 clearance and lung compliance remained in an acceptable range between over 15 and 30 min the patients were deemed suitable for VAD. If either the RV or pulmonary function was inadequate, extracorporeal membrane oxygenation (ECMO) may have been required.
Once the patient had been placed on VAD a pressure monitoring line was connected to the pump inlet. Change in inlet pressure is a good indicator of patient volume status and cannula placement problems. The centrifugal pump head generates suction in the atrial (venous) cannula. Care must be taken to keep this pressure above −20 mmHg, or excessive haemolysis will occur [2] . The VAD outlet pressure was also monitored to indicate aortic cannula problems and changes in arterial resistance.
Left heart bypass was commenced at minimal flow and quickly increased to 150 ml/min/kg. Immediately after the patients were satisfactorily on VAD, heparin was reversed with protamine to an activated clotting time (ACT) of 110 s, in an effort to attain surgical haemostasis. The sternum was generally left open and either a PFTE membrane was sutured to the skin edges or the skin alone was closed, with the cannulas exiting from either pole. When the patients were stable in ICU with minimal bleeding a heparin infusion was titrated to maintain an ACT of 160 -180 s. Patients were kept sedated and paralysed in ICU with full mechanical ventilation maintained. Inotropic support was reduced to the minimum level required to support the right heart. All patients received vasodilators, antibiotics, parenteral nutrition, and periodic fresh frozen plasma and platelet infusions as required.
Patients who suffered from low cardiac output postoperatively were cannulated and placed on VAD in the intensive care unit. They were heparinised for cannulation, and then the same reversal protocol was followed.
The patients were maintained on VAD for a minimum of 24 h, unless complications arose, before any assessment of ability to be weaned from VAD was made. After a minimum of 24 h the flow was reduced to allow some LV ejection at left atrial pressures of 8-10 mmHg. Using echocardiographic guidance increased fractional shortening and a positive Starling response on a reduced degree of VAD support were considered to be indications of myocardial recovery [3] . If the haemodynamics remained stable on the reduced VAD flow, the flow was reduced again. This procedure was continued until the patients were haemodynamically stable on minimal safe flow (approximately 200 ml/ min). At this point the patients were considered to be weanable. Precordial or transoesophageal echocardiography was used for this assessment.
Results
Twenty-two of the 35 procedures (0.63, 95% CI: 0.45-0.78) resulted in successful weaning and decannulation. Five patients could not be adequately supported by VAD for reasons of increased right atrial pressures, decreased oxygenation and poor CO 2 removal, and were converted to ECMO. Patients who could not be weaned had VAD support withdrawn. Bridging to transplant, although technically possible, was not usually undertaken due to the length of time typically required for procuring donor organs in Australia. Fourteen patients were discharged from hospital and 11 were alive 1 year post-discharge (Table 1) .
When all patients were considered, analysis of various patient parameters using Student's t-test and Fishers Exact test failed to identify factors predictive of successful or unsuccessful outcome (separation from VAD and/or hospital discharge; Table 2 ). However, if patients who were converted from VAD to ECMO were excluded, a statistically valid predictor of successful outcome could be identified ( Table 2 ).
All patients with TGA who had undergone an arterial switch and required VAD, without conversion to ECMO, survived to discharge, and all were alive 1 year post-discharge. There is an association between VAD duration and the probability of successful weaning from VAD in patients that did not need conversion to ECMO, but it does not extend to discharge from hospital. The mean VAD duration for those weaned successfully was 80.5 h compared to 43.8 h for those not weaned (P= 0.002). Those not weaned included one patient that could not be revived from a cardiac arrest and one patient that died due to complications caused by cannula displacement. Both of these events occurred within 8 h of the initiation of VAD support.
In interpreting these data, one must consider several factors in the difference in duration of support (weaned and non-weaned patients). Three patients with no sign of improvement in ventricular function in the first 48 h had support withdrawn within the next 48 h. Six patients became unsupportable, and two patients had P= 0.903 P = 0.181 P =0.126 VAD duration 3.
P =0.549 P =0.688 4.
CPB duration P =0.984 P =0.767 5.
X clamp duration Univentricular anatomy P = 0.296 6.
P= 0.283 TGA P= 0.099 7.
P =0.009 Failure to wean from CPB P =1.000 8. P= 1.000
All patients were under 6 kg and less than 259 days.
support withdrawn following VAD complications within 8 h of initiation of VAD. There were complications noted in 27 VAD patients. The most common complication was thrombus formation in the VAD circuit. This occurred in 13 patients, necessitating pump head changes in four and a circuit change in one. The remainder required no intervention. There were six patients that required surgical intervention to control bleeding, all among the first 10 procedures done. Five patients required conversion to ECMO, two patients had complications related to cannulae, and one needed the chest opened to facilitate cardiac massage. There were no permanent renal, neurologic or vascular sequelae in any of the survivors.
Discussion
Since described by DeBakey [4] in 1971, VAD has been used mainly in adult patients. Its use in neonates and small paediatric patients for support of post-operative ventricular failure after surgery for correction or palliation of congenital heart defects has largely not been well accepted for a number of cited reasons. These include technical difficulties related to size of patient [5 -7] , unsuitable anatomy [5, 8] and lack of experience [6] . In some institutions it has been overshadowed by the use of ECMO [6, 9, 10] . In comparison to centrifugal VAD, ECMO support requires a far more complicated circuit using an oxygenator and heat exchanger. Being more thrombogenic, ECMO use requires greater heparinisation of the patient [3] . Many patients with a univentricular circulation, as shown by Perko et al. [11] and this study, can be adequately supported by centrifugal VAD. In this series the survival to discharge probability is equivalent to that of patients supported by ECMO (40%) [12] , although, as we have experienced, some patients supported by ECMO have not been supportable by VAD. This study shows that in our institution patients under 6 kg have the same probability of survival to successful weaning from VAD as larger patients (P = 0.07). Recent literature has shown rates of survival to discharge that are similar to our own [13, 14] (Table 3) .
The main advantage of using centrifugal VAD to support a patient with potentially reversible ventricular failure is that it provides a reduction in pre-load and wall stress that can lead to a reduction in requirements of inotropic support. High levels of inotropic agents are associated with effects such as sinus tachycardia or arrhythmias, increased oxygen consumption and increased afterload.
Ratcliffe et al. [15] has shown that VAD can sharply improve myocardial function in dilated, poorly contracting hearts by reducing end-systolic and end-diastolic pressures and ventricular wall stress. Decreased left atrial pressure reduces pulmonary capillary hydrostatic pressure which can circumvent the need to increase ventilatory support and reduce the risk of right ventricular failure. [13] 7/13 1994 9 Scheinin et al. [12] 5/9 11/22 22 1997 Del Nido et al. [16] A VAD, by providing circulatory support to augment or replace low cardiac output, may prevent the development of ischaemic injury to other organs.
In this series of patients we have shown that centrifugal VAD can provide effective haemodynamic support in many patients under 6 kg who could not be weaned from CPB, or who suffered from low cardiac output post-operatively. This study has shown that centrifugal VAD in small post-cardiotomy patients with univentricular hearts or shunt dependent circulation can be successful. Thrombus formation is an ongoing problem and may be associated with the ACTs required for haemostasis by these patients and relatively low flow rates. Successful weaning from VAD does not ensure discharge from hospital. Patients who have undergone an arterial switch for correction of TGA have the best survival potential within the under 6 kg group.
